Final 12 months, I revealed a paper that confirmed that cancer mortality rates fell by 24% between 2000 and 2016 and further that new cancer drugs accounted for saving 1.3 million lives in the US over that time period. On the finish of the paper, we famous that these numbers could also be conservative since using new improvements–reminiscent of immuno-oncology, CAR-T remedy and others–took off after 2016.
It seems that our premonition was right, primarily based on the findings from the American Cancer Society’s 2021 Facts & Figures report.
From 1991 to 2018, the most cancers demise charge has fallen 31%. This features a 2.4% decline from 2017 to 2018—a brand new file for the most important 1-year drop within the most cancers demise charge.
Enhancements in well being behaviors (e.g., smoking) and new therapies have paved the best way for this enchancment, significantly for lung most cancers.
Reductions within the lung cancer demise rateaccount for nearly half of the entire drop within the most cancers demise charge from 2014 to 2018. That is considered resulting from declines in smoking, advances in early detection, and improved therapies, particularly for non-small cell lung most cancers (NSCLC), the commonest subtype.
Notice that the info don’t embody the affect of COVID-19 as they solely run by means of 2018. Additional, regardless of the dramatic enchancment in mortality, most cancers remains to be the #2 killer within the US (ignoring COVID), simply behind coronary heart illness. Nonetheless, COVID-19 has handed most cancers by way of US mortality within the spring and with the latest surge has virtually actually surpassed most cancers within the fall/winter of this 12 months.
As at all times, there may be a lot of attention-grabbing info within the ACS report.